Welcome and Announcements

Moderators: James B. Young, MD and Michael A. Acker, MD

Session II
From Bench to Bedside: Innovations in Heart Failure Medicine

Moderators: Randall C. Starling, MD, MPH and James K. Kirklin, MD

Featured Lecture and Kaufman Award Presentation
Floyd D. Loop, MD

Innovations in Heart Failure: The Economic Burden

Session III
Debatable Surgical Strategies for Heart Failure

Moderators: Bruce W. Lytle, MD and Craig R. Smith, MD

Moderate MR in Ischemic Cardiomyopathy: The valve should be fixed.

Pro: John A. Elefteriades, MD (10 min)
Con: Nader Moazami, MD (10 min)

5 min rebuttal
 

MV Repair in End-Stage Heart Failure

Pro: No Need for a Randomized Trial
Steven F. Bolling, MD (10 min)

Con: There is No Evidence of Benefit
Keith D. Aaronson, MD (10 min)

MV Annulopasty Rings

Pro: New Shapes Will Be the Answer.
David H. Adams, MD (10 mins)
 
Con: Shapes Won't Change a Thing!
Aubrey C. Galloway, MD (10 mins)

5 min rebuttal
 

Can We Avoid Randomized Clinical Trials for Heart Failure?
Eugene H. Blackstone, MD
 

Session IV
Acute Circulatory Support: Acute Myocardial Infarction and Post Cardiotomy

Moderators: Robert C. Robbins, MD and Gary S. Francis, MD

HELP! When to Call the Surgeon to the Coronary Care Unit.
Randall C. Starling, MD
 

What is the Best Short Term Support for Myocardial Recovery?
John G. Byrne, MD  
 

Post Myocardial Infarction Cardiogenic Shock: The TAH is the Only Way To Go.
Aly El-Banayosy, MD
 

Value of BVS 5000 to AB5000 Conversion: Does this make sense?
Louis E. Samuels, MD
 

Tandem Heart:Verastile pump for short term support.
James A. Magovern, MD
 

Session V
Destination Therapy: Tricks of the Trade

Moderators: Eric A. Rose, MD and Leslie W. Miller, MD

Destination Therapy in Non-Transplant Center: Why, when, and how?
Mark S. Slaughter, MD

Destination Therapy Patients Should Be Transplanted!
Edwin C. McGee Jr., MD

Pump Exchange: Making things easier.
Robert M. Adamson, MD

Are We Abandoning Pulsatile Pumps Too Soon?
James W. Long, MD

How Can We Complete These Trials?

Industry Perspective: Jeffrey W. Nelson
FDA Perspective: Bram D. Zuckerman, MD

Nuances of Medical Management in Advanced Heart Failure: Using evidence to guide practice.
Nancy M. Albert, PhD, RN
 

CRT/ICD Thoracic Impedance and Device Parameter Monitoring: Why, when and implications.
Stephen Miller, MSN, RN, ACNP
 

Translating Predictors of Post- Revascularization: Recovery into Action.
Kathleen L. Grady PhD, RN, FAAN
 

How to Insert a TAH?
 
Percutaneous Valves:

A Fib Surgery:

Coapsys:

Jack G. Copeland, MD

John G.Webb, MD

A. Marc Gillinov, MD

Aubrey C. Galloway, MD

Samir Kapadia, MD

Diagnosing HIT: What does PF4 and Serotonin release mean and does it matter?
George J. Despotis, MD
 

Anticoagulation for Devices: Lessons Learned from the TAH
Paul E. Nolan, PharmD

Direct Thrombin Inhibitors
Nicholas G. Smedira, MD

Managing Pulmonary Hypertension in LVADs and TAHs
Frank W. Smart, MD

Current Devices for Destination Therapy: Are they ready for prime time?

Pro: Richard N. Pierson III, MD (10 min)
Con: Steven E. Nissen, MD (10 min)

5 min rebuttal

Coraide
Aly El-Banayosy, MD

Ventrassist
Bartley P. Griffith, MD

HM II
Robert L. Kormos, MD

Jarvik
O. Howard Frazier, MD

Debakey
George P. Noon, MD

Impella
Bart P. Meyns, MD, PhD

Incor
Cristof Schmid, MD